← Evidence map

ReviewCancer gene therapy2024

CRISPR-Cas gene knockouts to optimize engineered T cells for cancer immunotherapy.

Valentine De Castro et al.PubMed ↗Publisher ↗

No numbers read from the abstract.

10 papers cite it

2024
2025
2026
this papercites it
Full record →Abstract, authors, funding and every citing paper · PMID 38609574